Page 3 - கெல்லி பூஞ்சை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from கெல்லி பூஞ்சை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In கெல்லி பூஞ்சை Today - Breaking & Trending Today

Apollomics, Inc. Licenses a Targeted, Active Checkpoint Control Immunotherapy for Greater China ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Apollomics, Inc. Licenses a Targeted, Active Checkpoint Control Immunotherapy for Greater China .
Apollomics, Inc.February 12, 2021 GMT
FOSTER CITY, Calif. and HANGZHOU, ZHEJIANG, China, Feb. 12, 2021 (GLOBE NEWSWIRE) Apollomics, Inc., an innovative biopharmaceutical company committed to the discovery and development of mono- and combination- oncology therapies, today announced an exclusive license agreement for the development and commercialization of TYG100 in Mainland China, Hong Kong, Macau and Taiwan, also known as Greater China, and South Africa.
TYG100 is an antigen-specific, active checkpoint control immunotherapy (ACCI) recombinant vaccine comprising the amino-terminal sequence of G17, a gastrointestinal peptide hormone, and utilizes the S-TIR™ technology platform. This technology induces a novel mechanism of action that is able to unmask tumors. TYG100 was ....

Jian Ni , Hong Kong , United Kingdom , South Africa , Remy Bernarda , Guo Liang Yu , Fred Jacobs , Kelly Fung , Wilsonw Cheung , Porda Havas International Finance Communications Group , Cancer Research United Kingdom , Corporate Communications , Apollomics Inc , Mainland China , Greater China , Cancer Research United , Nuance Biotech , Chief Executive Officer , Media Contact , Licensing Agreements , Corporate News , Pharmaceutical Manufacturing , Health Care Industry , East Asia , Diseases And Conditions , Globe Newswire ,

Apollomics, Inc. Licenses a Targeted, Active Checkpoint Control Immunotherapy for Greater China and South Africa

Apollomics, Inc. Licenses a Targeted, Active Checkpoint Control Immunotherapy for Greater China and South Africa
TYG100 utilizes proprietary S-TIR(TM) technology platform enabling specific B cell and T cell responses against tumor antigens
Foster City, CA & Hangzhou, CH, Feb 12, 2021 - (ACN Newswire) - Apollomics, Inc., an innovative biopharmaceutical company committed to the discovery and development of mono- and combination- oncology therapies, today announced an exclusive license agreement for the development and commercialization of TYG100 in Mainland China, Hong Kong, Macau and Taiwan, also known as Greater China, and South Africa.
TYG100 is an antigen-specific, active checkpoint control immunotherapy (ACCI) recombinant vaccine comprising the amino-terminal sequence of G17, a gastrointestinal peptide hormone, and utilizes the S-TIR(TM) technology platform. This technology induces a novel mechanism of action that is able to unmask tumors. TYG100 was developed by T ....

Jian Ni , Hong Kong , United Kingdom , South Africa , Remy Bernarda , Guo Liang Yu , Fred Jacobs , Kelly Fung , Wilsonw Cheung , Porda Havas International Finance Communications Group , Cancer Research United Kingdom , Corporate Communications , Asia Corporate News Network , Apollomics Inc , Greater China , Mainland China , Cancer Research United , Nuance Biotech , Chief Executive Officer , Media Contact , Asia Corporate News , ஜியான் நி , ஹாங் காங் , ஒன்றுபட்டது கிஂக்டம் , கூவோ லியாங் யூ , ஃப்ரெட் ஜாகோப்ஸ் ,

APL-106 (uproleselan) Granted Breakthrough Therapy Designation in China for the Treatment of Acute Myeloid Leukemia

APL-106 (uproleselan) Granted Breakthrough Therapy Designation in China for the Treatment of Acute Myeloid Leukemia
Foster City, CA, Hangzhou, CH, Gaithersburg, MD, Jan 07, 2021 - (ACN Newswire) - Apollomics, Inc., an innovative biopharmaceutical company committed to the discovery and development of mono- and combination- oncology therapies, and GlycoMimetics (Nasdaq: GLYC), today announced APL-106 (uproleselan) has been granted Breakthrough Therapy Designation (BTD) from the China National Medical Products Administration (NMPA) Center for Drug Evaluation (CDE) for the treatment of relapsed/refractory acute myeloid leukemia (AML).
This Breakthrough Therapy Designation for APL-106 reinforces its potential and is an important regulatory milestone for Apollomics as we prepare to initiate our clinical development work in China for patients suffering from AML, said Guo-Liang Yu, PhD, Co-Founder, Chairman and Chief Executive Officer. AML is an aggressive disease and relapsed ....

Hong Kong , Remy Bernarda , Jamie Lacey Moreira , Shari Annes , Guo Liang Yu , Yang Xiaofeng , Zhang Sufen , Zhang Qingyuan , Kelly Fung , Wilsonw Cheung , Porda Havas International Finance Communications Group , Asia Corporate News Network , Drug Administration , Exchange Commission , National Cancer Institute Surveillance , China National Medical Products Administration , Glycomimetics Inc , Corporate Communications , Apollomics Inc , Granted Breakthrough Therapy Designation , Acute Myeloid , Breakthrough Therapy Designation , Drug Evaluation , Chief Executive , Investigational New Drug , Drug Registration Regulation ,

Netflix, work from home, and other things Young Post is grateful for in 2020

Netflix, work from home, and other things Young Post is grateful for in 2020
3:12am, 28 Dec, 2020
From Joe Biden winning the US election, to quarantine pets, here’s what we appreciate most
Comment
2 Apr, 2021
2 Apr, 2021
2 Apr, 2021
2 Apr, 2021
2 Apr, 2021
1 Apr, 2021
We can all agree we re ready to leave 2020 behind - but there s still a few good things that happened this year.
It s been a tough old year, but not everything that happened in 2020 has been a complete bummer. It’s important to focus on the good, and express gratitude as it’s been proven to be good for your mental health.
As the year comes to a close, we took stock of some of the year’s events for which we are especially grateful – one serious piece of global news, one lighter piece of good news, and something positive that affected us personally. ....

Tuen Mun , Hong Kong General , Hong Kong , United Kingdom , Susan Ramsay , Dannie Higginbotham , Amalissa Hall , Anya Taylor , Joe Biden , Christopher Nolan , Tiger King , Robert Pattinson , Kelly Fung , Jose Andres , Tom Moore , Sad But True , Bly Manor , Captain Sir Tom Moore , துஎன் முன் , ஹாங் காங் ஜநரல் , ஹாங் காங் , ஒன்றுபட்டது கிஂக்டம் , சூசன் ராம்சே , டேனி ஹிகின்போதம் , அன்யா டெய்லர் , ஓஹோ பிடென் ,